Centre for Therapeutics Discovery

Therapeutic Approaches: Small Molecules, Biomarkers, Antibodies

Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Ophthalmology, Psychiatric Disorders, Pain

Center/Program Highlights: LifeArc is a charitable foundation that specialises in life science translational research and licensing. We offer early stage drug discovery, antibody engineering, diagnostics development and intellectual property management and commercialisation. In our laboratories we have more than 80 scientists (including an ex-pharma team of medicinal chemists and a biologics group with nearly a quarter century antibody engineering experience) working to create drug-like molecules to innovative new drug targets. We have a proven track record of success having produced four humanized antibodies with regulatory approval: Elan/Biogen Idecs Tysabri and Chugai/Roches Actemra, Millenium's Entyvio and Merck & Cos Keytruda.

Sources of Funding: Revenue


Institutional Affiliation(s): LifeArc

SBC Open Innovation Campus
Hertfordshire, SG1 2FX
United Kingdom

Center/Program Start Date: 2006

Number of Employees: 80